New Total Synthesis of O‐Methyledgeworin and Edgeworin
摘要:
Upon thermal condensation of diethyl (coumarinyl-7-oxy)malonate with O-methyl-resorcine, the corresponding bis[coumarinyl]ether, 4-hydroxy-O-methyledgeworin is obtained in good yield. This leads to 4-bromo-O-methyledgeworin, O-methyledgeworin, and edgeworin.
Inhibitors of DNA polymerase β: Activity and mechanism
作者:Zhijie Gao、David J. Maloney、Larisa M. Dedkova、Sidney M. Hecht
DOI:10.1016/j.bmc.2008.02.071
日期:2008.4
Bioassay-guided fractionation of extracts prepared from Couepia polyandra and Edgeworthia gardneri resulted in the isolation of the DNA polymerase beta (pol beta) inhibitors oleanolic acid (1), edgeworin (2), betulinic acid (3), and stigmasterol (4). Study of these pol b inhibitors revealed that three of them inhibited both the lyase and polymerase activities of DNA polymerase beta, while stigmasterol inhibited only the lyase activity. Further investigation indicated that the four inhibitors had substantially different effects on the DNA-pol beta binary complex that is believed to be an obligatory intermediate in the lyase reaction. It was found that the inhibitors potentiated the inhibitory action of the anticancer drug bleomycin in cultured A549 cells, without any influence on the expression of pol beta in the cells. The results of the unscheduled DNA synthesis assay support the thesis that the potentiation of bleomycin cytotoxicity by DNA pol beta inhibitors was a result of an inhibition of DNA repair synthesis. (C) 2008 Elsevier Ltd. All rights reserved.
BABA, KIMIYE;TABATA, YUKO;TANIGUTI, MASAHIKO;KOZAWA, MITSUGI, PHYTOCHEMISTRY, 28,(1989) N 1, C. 221-225
METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS
申请人:HE Cheng
公开号:US20090170930A1
公开(公告)日:2009-07-02
A method for promoting differentiation of clonogenic neural stem cells (NSCs), comprising administering to a patient in the need of such promoting a coumarin compound represented by formula I or by formula II. The representative coumarin compounds include 7-hydroxycoumarin, daphnoretin, scopoletin, edgeworin, aesculetin and esculetin-6-β-D-glucopyranoside. The coumarin compounds showed significant activity of directing the differentiation of NSCs in pharmacological test and thereof could be used to prepare drugs to direct NSCs differentiated to oligodendrocyte progenitor cells (OPCs) for the treatment of demyelinating diseases or spinal cord injury. The drug could be a pure coumarin compound or a pharmaceutical composition comprising a therapeutical dose of a coumarin compound as active ingredients and a pharmaceutically-acceptable carrier. The content of the active ingredients in the pharmaceutical composition is between 0.1% and 99.5% by weight.
Abstract Two new coumarins, edgeworin and edgeworoside A, were isolated from the root and stem of Edgeworthiachrysantha ( E. papyrifera ) and their structures determined as 3-(7-coumarinyloxy)-7-hydroxycoumarin and 3-(7-coumarinyloxy)-8-(7-hydroxycoumarin-8-yl)-7-α- l -rhamnopyranosyloxycoumarin.
New Total Synthesis of O‐Methyledgeworin and Edgeworin
作者:B. Serge Kirkiacharian、Marie Brillard
DOI:10.1080/00397910500406088
日期:2006.3.1
Upon thermal condensation of diethyl (coumarinyl-7-oxy)malonate with O-methyl-resorcine, the corresponding bis[coumarinyl]ether, 4-hydroxy-O-methyledgeworin is obtained in good yield. This leads to 4-bromo-O-methyledgeworin, O-methyledgeworin, and edgeworin.